HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions
暂无分享,去创建一个
Giuseppe Cicero | A. Russo | V. Bazan | G. Bronte | G. Cicero | M. Castiglia | D. Fanale | S. Caruso | Giuseppe Bronte | Marta Castiglia | Antonio Russo | Viviana Bazan | Daniele Fanale | Stefano Caruso | Lidia Rita Corsini | Lavinia Insalaco | L. Corsini | L. Insalaco
[1] P. V. van Diest,et al. HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers , 2013, PloS one.
[2] Gordon K. Smyth,et al. affylmGUI: a graphical user interface for linear modeling of single channel microarray data , 2006, Bioinform..
[3] H. Iwase,et al. Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer , 2008, Breast Cancer Research and Treatment.
[4] K. Stoeber,et al. The cell cycle and cancer , 2012, The Journal of pathology.
[5] V. Adamo,et al. The role of Aurora-A inhibitors in cancer therapy. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] Stephen L. Brown,et al. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas , 2012, Cell cycle.
[7] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[8] R. Lech,et al. Epidemiological models for breast cancer risk estimation. , 2011, Ginekologia polska.
[9] H. Mori,et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. , 1999, Cancer research.
[10] Brian Keith,et al. Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation , 2003, Molecular and Cellular Biology.
[11] A. Harris,et al. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. , 2001, Anticancer research.
[12] Adrian L Harris,et al. Hypoxia and oxidative stress in breast cancer: Hypoxia and tumourigenesis , 2001, Breast Cancer Research.
[13] M. Pagano,et al. Constitutive Phosphorylation of Aurora-A on Ser51 Induces Its Stabilization and Consequent Overexpression in Cancer , 2007, PloS one.
[14] Peter Vaupel,et al. The role of hypoxia-induced factors in tumor progression. , 2004, The oncologist.
[15] G. Gopalan,et al. Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells. , 2007, Endocrine-related cancer.
[16] Choa Park,et al. Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. , 2011, Biochemical and biophysical research communications.
[17] J. Bussink,et al. Molecular aspects of tumour hypoxia , 2008, Molecular oncology.
[18] D. Fisher,et al. Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF , 2011, Proceedings of the National Academy of Sciences.
[19] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[20] J Martin Brown,et al. Tumor Microenvironment and the Response to Anticancer Therapy , 2002, Cancer biology & therapy.
[21] J. Simons,et al. Hypoxia-inducible factor-1 in human breast and prostate cancer. , 2006, Endocrine-related cancer.
[22] J. Ingels,et al. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer , 2012, Breast Cancer Research.
[23] Qing Jiang,et al. Roles of Aurora Kinases in Mitosis and Tumorigenesis , 2007, Molecular Cancer Research.
[24] Ko-Fan Chen,et al. Transcriptional repression of human cad gene by hypoxia inducible factor-1α , 2005, Nucleic acids research.
[25] F. Gergely,et al. Aurora-A: the maker and breaker of spindle poles , 2007, Journal of Cell Science.
[26] G. Semenza,et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.
[27] A. Dunker,et al. Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data , 2008, BMC Medical Genomics.
[28] W. Kaelin,et al. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. , 2003, Journal of the American Society of Nephrology : JASN.
[29] R. Medema,et al. Shared and separate functions of polo-like kinases and aurora kinases in cancer , 2010, Nature Reviews Cancer.
[30] G. Semenza. Signal transduction to hypoxia-inducible factor 1. , 2002, Biochemical pharmacology.
[31] C. Pugh,et al. Hypoxia and oxidative stress in breast cancer: Hypoxia signalling pathways , 2001, Breast Cancer Research.
[32] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[33] Ahmedin Jemal,et al. Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[34] T. Kietzmann,et al. Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. , 2008, Molecular biology of the cell.
[35] S. Lens,et al. The Aurora kinase family in cell division and cancer. , 2008, Biochimica et biophysica acta.
[36] A. Jukkola-Vuorinen,et al. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients , 2012, Breast Cancer Research and Treatment.
[37] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[38] Y. Benjamini,et al. Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.
[39] Huan Yang,et al. Aurora‐A induces cell survival and chemoresistance by activation of Akt through a p53‐dependent manner in ovarian cancer cells , 2006, International journal of cancer.
[40] A. Sood,et al. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation , 2012, Cell cycle.
[41] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] Hiroshi Katayama,et al. The Aurora kinases: Role in cell transformation and tumorigenesis , 2003, Cancer and Metastasis Reviews.
[43] A. Jemal,et al. Breast Cancer Statistics , 2013 .
[44] C. Golias,et al. Cell proliferation and cell cycle control: a mini review , 2004, International journal of clinical practice.
[45] P. Maxwell,et al. VHL inactivation induces HEF1 and Aurora kinase A. , 2010, Journal of the American Society of Nephrology : JASN.
[46] Feng Jiang,et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. , 2002, Journal of the National Cancer Institute.
[47] Hagen Schmal,et al. Development and Characterization of a Spheroidal Coculture Model of Endothelial Cells and Fibroblasts for Improving Angiogenesis in Tissue Engineering , 2005, Cells Tissues Organs.
[48] A. Giordano,et al. R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair , 2010, Molecular Cancer.
[49] Melissa L. Johnson,et al. Emerging targeted therapies for breast cancer. , 2007, Hematology/oncology clinics of North America.
[50] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[51] Manfred Kunz,et al. Molecular responses to hypoxia in tumor cells , 2003, Molecular Cancer.
[52] D. Xing,et al. The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway. , 2010, Cancer research.
[53] Simon Lord,et al. Gene expression and hypoxia in breast cancer , 2011, Genome Medicine.
[54] H. Frierson,et al. Expression profiling of gastric adenocarcinoma using cDNA array , 2001, International journal of cancer.